Skip to main content
. 2022 Jun 1;13:863448. doi: 10.3389/fendo.2022.863448

Table 2.

Subgroup analysis of HGS.

Subtotal (n) Number of studies (n) WMD (95% CI) P-value
Age
>50 2,736 4 1.353 (−0.238; 2.944) 0.096
>60 870 4 1.116 (0.433; 1.799) 0.001
>70 623 2 −0.379 (−0.944; 0.186) 0.189
With calcium or not
with calcium 3,816 6 0.478 (−0.165; 1.122) 0.145
without calcium 413 4 1.931 (0.166; 3.697) 0.032
Baseline serum vitamin D level
<30 ng/ml 1,125 6 1.445 (0.486; 2.403) 0.527
>30 ng/ml 757 3 0.478 (−0.963; 1.918) 0.003
Vitamin D dosage (IU/day)
<1,000 2,769 3 0.206 (−0.218; 0.630) 0.341
≥1,000 847 3 0.161 (−0.911; 1.234) 0.768
vitamin D analogs 613 4 2.118 (1.024; 3.213) 0
Supplementation duration
>12 3,059 3 0.621 (−0.219; 1.461) 0.147
<12 1,170 7 1.193 (−0.090; 2.477) 0.068

WMD, weighted mean difference; CI, confidence interval.